SQI Diagnostics

SQI Diagnostics Inc. is a life sciences company based in Toronto, Canada, specializing in the development and commercialization of proprietary technologies for multiplexing diagnostics. The company offers a variety of products and services designed to detect and quantify proteins, antibodies, and DNA. Key systems include sqidworks, which automates plate loading and reporting, sqidlite, a benchtop system for processing single plates, and sqid-X, which utilizes Ig_plex technology for multiplexing. SQI's offerings cater to various applications, including immunogenicity and bioanalysis, in vitro diagnostics, and assay development. The company primarily serves markets in pharmaceutical and biotechnology drug development, human diagnostic testing, and animal health diagnostics. Founded in 1999, SQI Diagnostics is recognized for its innovations in respiratory health and precision medicine tests, particularly in areas such as COVID-19 antibody monitoring and acute lung injury testing. Its operations extend across the United States, Canada, and Europe, with Canada generating over half of its revenue.